Q1 Productions’ 10th Annual Life Science Medical & Scientific Communications Conference to Facilitate Effective Medical Communication Strategies

July 14, 2021 13:20:25
Date: July 27-29, 2021  Virtual Event Companies and professionals from the pharma, biotechnology, medical device and diagnostic fields are invited to attend the Q1 Productions’ 10th Annual Life Science Medical & Scientific Communications Conference being held on July 27-29, 2021. This online event will witness many industry leaders in medical communication who will share their opinions, keynotes and hold discussions on streamlining and improving communication. The conference will host case studies and group discussions addressing the techniques of integrating digital capabilities into publication operations, compliance considerations for disease awareness communications and engagement strategies for patients and external stakeholders. This online streaming conference is a great opportunity to collaborate with industry professionals to streamline and enhance medical communication operations. The event will be hosted on the dynamic Q1 Productions virtual platform that customizes the user experience by connecting attendees with their peers. Attendees will get answers to their queries while the dynamic formats ensure that participants enjoy the virtual experience. The event covers a span of 3 and half days for maximum retention and coverage of the wide spectrum of medical communications. BioMedWire (“BMW”), a technology-driven communications platform, is the media partner of the event. This digital hub connects the public to emerging market opportunities in life sciences and beyond. Important topics to be covered in the conference agenda include:
  • Impactful medical communication strategies in an evolving medical industry
  • Uses and impact of diseases exploration campaigns
  • Adapting and implementing new methods of virtual interaction and digital interaction
  • Assessing overall experiences with virtual congresses and strategies to promote HCP engagement
  • Creating engaging and impactful virtual advisory board agendas for advisory meetings
  • Understanding and addressing the future of advisory boards in hybrid meetings
  • Promoting collaboration between medical communication and cross-functional teams
  • Evaluation of content and training needs from cross-functional and local teams
  • Co-creation of unique content to ensure local and cross-functional approval/adoption
  • Determining the need for centralized vs. decentralized global teams for Cultural consideration
  • Raising awareness about the release of upcoming publications & use of personal social media accounts
  • Opportunities available to medical affairs teams with social outreach; increased social media outreach during the pandemic
Q1 productions have a Virtual Event Guide & FAQ forum for a better user experience. The mobile app Q1 Events offers all networking experiences of the virtual platform for a seamless experience. For more information about the event, please visit https://ibn.fm/0xfKV.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.